The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
New HIV vaccine trial builds on success of 2009 Thai trial that showed 31.2% effectiveness in preventing HIV.
Over 300,000 AIDS-related deaths each year could be prevented through better diagnosis and treatment of fungal infections
Viral load testing could become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.
The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.
A once-a-week injection that can offer ‘complete viral-load suppression’ for up to 17 months, could be available from 2017 according to Pharmaceutical company CytoDyn Inc. following a trial of 23 patients.
HIV still replicates within the lymphoid tissues, even when people are on antiretroviral treatment and have an undetectable viral load, according to scientists at Northwestern University in the USA.
This new research, published in the journal Nature (January 27), provides valuable insight into why and how HIV remains so difficult to treat and cure.
People living with HIV with suppressed viral loads may, for the first time, be offered long-acting, injectable antiretroviral treatment, following a clinical investigation by two global pharmaceutical companies.
